Table 1 Effect of RSVA314 and RSVA405 treatment on adipogenesis-induced gene expression changes in 3T3-L1 cells.

Ceacam1

3.04 ± 0.37^a

0.60 ± 0.12^b

0.81 ± 0.26^b

Trib3

0.08 ± 0.03^a

0.72 ± 0.14^b

0.69 ± 0.08^b

PPARg

1.57 ± 0.05^c

0.72 ± 0.04^b

0.67 ± 0.06^b

Agt

5.46 ± 2.17^c

0.36 ± 0.17^b

0.36 ± 0.12^b

Pik3r1

1.59 ± 0.12^c

0.87 ± 0.07^b

0.84 ± 0.06^b

Cebpa

2.79 ± 0.21^c

0.70 ± 0.07^d

0.74 ± 0.06^d

Retn (resistin)

4.95 ± 0.45^c

1.12 ± 0.05^d

1.24 ± 0.22^d

Slc2a4 (GLUT4)

11.20 ± 7.41^c

2.48 ± 1.55^d

1.47 ± 0.28^d

Snap25

4.94 ± 1.23^c

1.11 ± 0.04^d

1.23 ± 0.21^d

Srebf1

1.79 ± 0.04^c

0.96 ± 0.08^d

0.91 ± 0.05^d

Foxc2

1.94 ± 0.06^c

1.13 ± 0.16^d

1.13 ± 0.10^d

Ccl5 (RANTES)

0.54 ± 0.07^e

1.12 ± 0.17^b

1.74 ± 0.20^b

Gpd1

1.67 ± 0.31^e

0.78 ± 0.16^b

0.39 ± 0.18^b

Vamp2

0.76 ± 0.09^e

1.42 ± 0.13^b

1.18 ± 0.19^d

Pfkfb3

2.45 ± 0.91^e

1.04 ± 0.51^d

1.33 ± 0.45^d

II4ra

1.53 ± 0.01^e

1.03 ± 0.07^f

0.75 ± 0.09^d

Igfbp5

3.73 ± 0.87^e

1.12 ± 0.05^f

1.24 ± 0.22^f

Nrf1

0.73 ± 0.05^e

0.97 ± 0.03^f

0.96 ± 0.03^f

Ace

2.49 ± 0.46^e

1.87 ± 0.51

1.24 ± 0.22^f

Icam1

0.31 ± 0.13

2.03 ± 0.51

2.23 ± 0.35^f